« Back to Record
Citation APA

Cinquegrani, G. G., Spigoni, V., Fantuzzi, F., Bonadonna, R. R., & Dei Cas, A. (2022). Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics. Cardiovascular diabetology.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/351074

Cinquegrani, G. G., Spigoni, V., Fantuzzi, F., Bonadonna, R. R., & Dei Cas, A. (2022). Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics. Cardiovascular diabetology.